Clinical preference for factors in treatment of geriatric depression

Clinical preference for factors in treatment of geriatric depression

Matthias W Riepe Mental Health and Geriatric Psychiatry, Psychiatry II, Ulm University, Ulm, Germany Abstract: Little is known about symptom preferences of clinical psychiatrists in the treatment of geriatric depression and preferences for avoiding adverse drug effects. Participants (bo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Riepe MW
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/0bdeb43578aa4a1b9061705e55cd9704
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0bdeb43578aa4a1b9061705e55cd9704
record_format dspace
spelling oai:doaj.org-article:0bdeb43578aa4a1b9061705e55cd97042021-12-02T01:15:33ZClinical preference for factors in treatment of geriatric depression1178-2021https://doaj.org/article/0bdeb43578aa4a1b9061705e55cd97042014-12-01T00:00:00Zhttp://www.dovepress.com/clinical-preference-for-factors-in-treatment-ofnbspgeriatric-depressio-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021 Matthias W Riepe Mental Health and Geriatric Psychiatry, Psychiatry II, Ulm University, Ulm, Germany Abstract: Little is known about symptom preferences of clinical psychiatrists in the treatment of geriatric depression and preferences for avoiding adverse drug effects. Participants (board-certified psychiatrists) were recruited prior to a lecture on geriatric depression during a continuing education program. An analytic hierarchy process was performed and participants were asked for pairwise comparison of criteria guiding them in appraising therapeutic efficacy, and in avoiding toxicity and adverse events. Of the 61 participants from the continuing education program, 42 (69%) returned their data sheet. Avoidance of cardiotoxicity was regarded as more important than avoidance of hepatotoxicity or hematotoxicity. Concerning adverse events, highest preference was given to avoidance of falls and drug interactions, followed by avoidance of sedation, weight change, and impairment of sexual function. The most important preferences for appraisal of therapeutic efficacy were suicidality over ability to concentrate and sleep. Clinical psychiatrists have a hierarchy of preferences for treatment goals and avoidance of adverse events and toxicity. This raises the question for future research whether these preferences cause differences in prescription patterns in clinical practice even though a multitude of antidepressants are similarly effective when judged with instruments used in clinical trials. Keywords: depressive disorder, symptoms, analytic hierarchy process, toxicity, adverse events, symptomsRiepe MWDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 25-31 (2014)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Riepe MW
Clinical preference for factors in treatment of geriatric depression
description Matthias W Riepe Mental Health and Geriatric Psychiatry, Psychiatry II, Ulm University, Ulm, Germany Abstract: Little is known about symptom preferences of clinical psychiatrists in the treatment of geriatric depression and preferences for avoiding adverse drug effects. Participants (board-certified psychiatrists) were recruited prior to a lecture on geriatric depression during a continuing education program. An analytic hierarchy process was performed and participants were asked for pairwise comparison of criteria guiding them in appraising therapeutic efficacy, and in avoiding toxicity and adverse events. Of the 61 participants from the continuing education program, 42 (69%) returned their data sheet. Avoidance of cardiotoxicity was regarded as more important than avoidance of hepatotoxicity or hematotoxicity. Concerning adverse events, highest preference was given to avoidance of falls and drug interactions, followed by avoidance of sedation, weight change, and impairment of sexual function. The most important preferences for appraisal of therapeutic efficacy were suicidality over ability to concentrate and sleep. Clinical psychiatrists have a hierarchy of preferences for treatment goals and avoidance of adverse events and toxicity. This raises the question for future research whether these preferences cause differences in prescription patterns in clinical practice even though a multitude of antidepressants are similarly effective when judged with instruments used in clinical trials. Keywords: depressive disorder, symptoms, analytic hierarchy process, toxicity, adverse events, symptoms
format article
author Riepe MW
author_facet Riepe MW
author_sort Riepe MW
title Clinical preference for factors in treatment of geriatric depression
title_short Clinical preference for factors in treatment of geriatric depression
title_full Clinical preference for factors in treatment of geriatric depression
title_fullStr Clinical preference for factors in treatment of geriatric depression
title_full_unstemmed Clinical preference for factors in treatment of geriatric depression
title_sort clinical preference for factors in treatment of geriatric depression
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/0bdeb43578aa4a1b9061705e55cd9704
work_keys_str_mv AT riepemw clinicalpreferenceforfactorsintreatmentofnbspgeriatricdepression
_version_ 1718403179149787136

Ejemplares similares